Form4insider filings, from the source

SEC Form 4 · accession 0000921895-17-002355

Enveric Biosciences, Inc. · ENVB

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Jeffrey E. Eberwein
Director · 10% Owner
Period of report
Sep 26, 2017
Accepted (ET)
Sep 28, 2017 · 7:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000890821

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2,F3Sep 26, 2017X1,205,837—A2,872,592IBy: Lone Star Value Investors, LP
9.00% Series A Cumulative Preferred StockF1,F3holding———373,708IBy: Lone Star Value Investors, LP
Common StockF1,F4holding———83,308IBy: Separately Managed Account
Common StockF1holding———27,066D
Common StockF1,F5holding———10,104IBy: Lone Star Value Co-Invest I, LP

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Warrant (Right to Buy)F2,F3—Sep 26, 2017X1,666,666DMay 26, 2015May 26, 2020Common Stock1,666,6660I

Explanation of responses